All companies
Visit website
OVUM HEALTH
OperatingOVUM HEALTH INC.
Healthcare · Founded 2023
Proven fertility treatment at home, covered by insurance
Post-money valuation ⓘ
$12.0M
As of Oct 2024 · from Ovum Health Common Stock 1 · pre-money + amount raised, not a traded price
Total raised
$54,582
Across 1 round since 2024
Latest share price
$1.24
Ovum Health Common Stock 1 offering price
Financials
FY2022–FY2023 · from SEC filings · hover any figure for its source$0
2022
$47K
−$305K
2023
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2022
FY2023
Income statement
Revenue
$0
$47,272
Cost of goods sold
$0
$0
Gross margin
—
100%
Net income
$0
-$305,320
Taxes paid
$0
$0
Balance sheet
Cash
$0
$4,117
Accounts receivable
$0
$37,929
Total assets
$0
$42,046
Short-term debt
$0
$33,923
Long-term debt
$0
$312,500
Total liabilities
$0
$346,423
Other
Headcount
—
9
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$12.0M
post-money
Ovum Health Common Stock 1
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $54.6K / $618KInvestors 44Post-money $12M
Reg CF annual-report compliance
Delinquent
Filed 0 of 2 annual reports (FY2024–FY2025)
Missing: 2024, 2025
44 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
Source: ManualCIK 0002035024Share price $1.24
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.